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The need to establish and develop formal biobanks in South Africa 
(SA), especially for human biological samples, is increasing.[1] 
Internationally funded initiatives such as Human Heredity and 
Health in Africa (H3Africa), and various investments into HIV, 
tuberculosis (TB) and malaria research, are creating awareness of the 
value of high-quality human biospecimen availability for health and 
disease research.[1] As such, academic institutions find themselves 
at the forefront of a drive to invest in the development of secure, 
affordable and convenient storage facilities for human samples. This 
fast-evolving scientific field brings with it many social and ethical 
issues that require careful consideration.[2,3] The University of the 
Witwatersrand, Johannesburg (Wits), has taken the lead in promoting 
the establishment of high-quality biobanks and biobanking practices 
in the region, and in addressing the legal and ethical implications for 
biobanking in SA.[2]
The Sydney Brenner Institute for Molecular Bioscience (SBIMB) 
is a cross-disciplinary research institute at Wits. The institute 
offers postgraduate students and collaborating researchers the 
resources to perform high-quality and high-impact research with 
a focus on critical questions related to the health of African 
populations. The SBIMB has a growing platform of expertise in 
the fields of human genetics and genomics, population genetics, 
bioinformatics, evolutionary biology and biomedical informatics, 
with an extensive network of collaborators globally. Our objective, to 
develop capacity for genomic research in Africa, is in line with that of 
the H3Africa consortium, and our involvement in studies of African 
and SA population genetics and clinical studies in ophthalmology, 
rheumatology, cancers, cardiometabolic diseases and obesity is all 
focused on African cohorts. This article documents the challenges 
experienced in the establishment of the SBIMB biobank and specific 
considerations for biobanking in SA, as well as providing a summary 
of 10 critical issues to address before embarking on a biobanking 
venture in a low-resource setting. 
Governance 
A well-established system of governance is essential for the 
development of good policies, and for monitoring their 
implementation. Managing ethical, legal and social implications is 
critical for any biobank, and the attendant regulations will necessarily 
and desirably be burdensome. The SA legal framework currently 
makes no provision for the regulation or governance of biobanking.[2-4] 
The amendments made in 2012 to the National Health Act No. 61 of 
2003 apply to tissue and stem-cell banking for clinical purposes, but 
not to biobanking in general.[5] They leave the regulation of biobanks 
in the hands of ethics regulatory bodies, rather than within a legal 
framework, and the regulations regarding the storage, use and re-use 
of DNA are vague.[2,4,6)
Recommendations for regulations specific to biobanking in SA and 
across national African borders have been made, and an important 
issue that was raised was genomic sovereignty.[4,6] Developing genomic 
capacity in Africa, rather than exporting DNA samples for storage 
and analysis to higher-income countries, is essential.[6] The inherent 
genomic diversity of African populations is important in order to 
better understand disease aetiology. To prevent exploitation, special 
attention should be given to drafting material transfer agreements 
(MTAs) that specifically outline benefits to both parties, and disallow 
misuse or further use of samples for purposes other than those of the 
original agreement, unless agreed to in writing.[2,6] Through the Wits 
Biobanks Ethics Committee (BEC), an MTA document was drafted 
and approved for use for Wits research.[4,7] This document emphasises 
the importance of informed consent, benefit sharing and ownership 
of biospecimens through transfer across national boundaries.[4] It 
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is available on the Wits website, and is a valuable guideline when 
drafting MTAs for the transfer of human biospecimens in Africa and 
globally.[4]
Wits stipulates that approved biobanks should be registered with the 
SA Department of Health; however, there is currently no mechanism 
to do so. Regulatory bodies therefore need to develop policies and 
guidelines for biobanking in SA in order for the proper ethicolegal 
regulation of biobanking to occur.[2-4] A working group, comprising 
members from various academic institutions representing the interests 
of research and biobanking in SA, has been constituted to address 
these issues. The Bridging Biobanking and Biomedical Research 
across Europe and Africa (B3Africa) initiative is looking to align the 
biobanking frameworks in Africa with those already established in 
Europe, through the collaboration of their 11 partners.[8]
The SA National Health Research Ethics Council develops 
guidelines for health research ethics committees, which have the 
responsibility to regulate research involving human subjects. The 
Wits Human Research Ethics Committee (HREC) (Medical), which 
is further advised by the Wits BEC subcommittee, regulates biobanks 
that store samples for research purposes at the university.[2,4] The 
BEC was officially constituted in 2013, as Wits took the initiative to 
establish regulations at an institutional level for biobanking.[2,4] The 
BEC stipulates their requirements under either public- or private-
sector biobanks. As the SBIMB biobank is neither of these, and 
functions as a small-scale academic biobank, the application process 
was challenging. Ethics approval (ref. no. M1403107) was granted in 
2015, and is valid for 5 years, with the allowance for audits or visits 
from members of the BEC. The SBIMB biobank is the first academic 
biobank to be approved by the Wits HREC, and follows the approval 
of two commercial service provider biobanks in Johannesburg. Future 
requirements for accreditation with the SA National Accreditation 
Body[9] strengthen the need for the involvement of the government, 
medical and regulatory bodies and legislation to provide SA biobanks 
with the means for the equivalent certification that is available 
elsewhere.
The SBIMB biobank has a governance structure for independent 
oversight through the SBIMB advisory board, which has both 
local and international representation. Internally, the Biobank 
Scientific Advisory Committee (BSAC) consists of a group of 
multidisciplinary individuals with a range of expertise, including 
clinicians, epidemiologists, geneticists, bioinformaticists and 
individuals with ethico-legal expertise. The BSAC manages access to 
both samples and associated data. Each request is assessed to ensure 
that ethical requirements have been met and that the research is in 
line with the informed consent provided by the participants, and 
the values and objectives of the SBIMB. The biobank management 
group is responsible for the daily running of the SBIMB biobank 
(Fig. 1). This system of governance ensures protection of the rights 
of research participants, regulates access to samples, and allows for 
future research in a manner that agrees with the ethical principles of 
beneficence, non-maleficence, respect for autonomy and justice, as 
well as being aligned with national and international guidelines and 
regulations which conform to the ideals of the Declaration of Taipei.
The Declaration of Taipei specifically focuses on the ethical 
considerations of biobanking.[10] It encompasses the collection, 
storage and use of human biospecimens beyond immediate 
healthcare and into the realm of public health.[10] This means that 
researchers are obliged to ensure that the rights of their participants 
are doubly protected.[10] Some informed-consent models are not 
adequate for biobanking, as they do not take into account the future 
use of participants’ samples for unrelated research studies.[2,11] Broad 
consent allows ethical regulation of the use of biospecimens and data 
for research other than that stated in the original informed-consent 
document.[2-4,11] This implies that a strict governance framework is 
required to prevent misuse of stored samples and data, and to address 
the problems of exploitation and stigmatisation.[4,10,11] Community 
engagement and regular feedback on research outcomes are good 
ways to broaden understanding about research participation and its 
possible benefits to global health.[10,11] 
All SBIMB biobank personnel are required to complete the 
National Institutes of Health (NIH) Protection of Human Participants 
online course annually, and to adhere to the policies and procedures 
outlined by the SBIMB, Wits,[12] the H3Africa consortium[13,14] and 
International Society for Biological and Environmental Repositories 
(ISBER).[15] The SBIMB biobank has no direct contact with the 
research participants whose samples are stored. The principal 
investigator (PI) of each research project storing samples in the 
biobank must provide a copy of the ethics clearance certificate, 
templates of the original informed-consent documents stating 
withdrawal options, an information sheet and an undertaking that all 
the donors of biospecimens submitted have signed consent forms. All 
samples are coded with a unique identifier that can only be linked to 
the participant by the project’s PI, meaning that the SBIMB biobank 
has no access to personal identifying information. The minimum 
data accompanying each sample do not permit identification of 
participants, and related phenotypic, demographic and genomic 
data are not stored within the biobank, nor can they be accessed by 
unauthorised individuals. Details of consent are documented per 
study, and provision is made for specifying the use and sharing of 
samples and related data. The SBIMB biobank respects the rights 
of participants to withdraw from research projects. This is done 
following written instruction from the project PI for withdrawal and 
disposal of biological samples and data. 
Infrastructure, sample management 
and storage 
Location is an important factor to consider in academic research; 
researchers are more likely to make use of services if the biobank 
is easy to find and nearby, to limit the use of expensive couriers. 
Environment- and resource-specific factors may limit the feasibility 
of establishing a biobank, so it is advisable to consider the strengths 
and weaknesses of such a project. 
Independent oversight
SBIMB Advisory Board (SAB)
Biobank Scientic Advisory Committee (BSAC)
Management group
Policies
Sample repository Relational database
Managed access
Ethics oversight Wits 
HREC (Medical) and BEC
Fig. 1. SBIMB Biobank Governance: A managed sample and data access 
process for the SBIMB biobank is governed through various levels of 
regulation including independent oversight by the SBIMB Advisory 
Board (SAB) and internal governance by the Biobank Scientific Advisory 
Committee (BSAC), all overseen by the Wits Human Research Ethics 
Committee (HREC (Medical)) and Biobanks Ethics Committee (BEC).
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In the case of the SBIMB biobank, potential modifications to the 
building were limited owing to the fact that the SBIMB is based on 
a national heritage site. The biobank itself is 70 m2 in size; therefore, 
only DNA and buffy coat samples are stored onsite, at –80°C. 
The size of the main laboratory, along with restrictions from the 
heritage council, prevents the installation of onsite CO2 backup 
cylinders, which presented a challenge due to the unstable power 
supply experienced in SA. To mitigate against the occasional loss 
of electricity, the SBIMB biobank runs on redundant power supply. 
In addition to the municipal supply, it has an uninterrupted power 
supply (UPS) with an extra battery, and a diesel generator capable of 
maintaining electricity levels for up to 48 hours per tank of diesel, 
and which can be topped up while running. It was necessary to 
consider site-specific modifications or risk preventive measures. 
For example, thunderstorms are common in Johannesburg in the 
summer and can cause power surges and outages, which necessitated 
the installation of earth mats and isolators. A biobank must have 
a back-up facility in close proximity that is capable of storing all 
samples in an emergency situation. The ambient temperature of the 
main laboratory and the temperatures of the fridges and freezers 
are monitored daily. The COMET temperature data monitoring 
system probes, which take temperature readings every 10 minutes, 
are linked  to a modem that sends out text notifications at 
predetermined alarm-triggering temperatures, which for the ultra-
low temperature freezers is –70°C. 
Biobank personnel are trained to extract DNA from various 
sample types (whole blood, buffy coat, saliva, buccal swabs and stool 
samples). At least two aliquots of DNA are stored per participant. One 
aliquot is frozen at –80°C, while the other is refrigerated as a working 
aliquot. The working aliquot prevents multiple freeze-thaw cycle 
degradation of DNA. Ensuring high-quality DNA samples does not 
just rely on adequate storage, but may be affected by pre-analytical 
handling of samples (e.g. whole blood) from collection through 
to processing. A strict internal quality control (IQC) regimen is 
essential. An initial assessment of the quality of the samples received 
should be considered as part of the quality control (QC) process. 
Generally, whole blood and buffy coat samples that are clotted, 
or that have been stored inappropriately, perform poorly during 
automated extraction, because the tips or needles are unable to take 
up the sample. Their DNA yields are therefore much lower than the 
average expected yield for manual extractions in these cases (below 
80 µg). DNA concentration and purity (260/280 ratio indicating 
protein contamination) should be assessed using spectrophotometry 
(Nanodrop, Thermo Fisher Scientific, USA), although fluorometric 
(Qubit, Life Technologies, Singapore) methods provide a more 
accurate measure of double-stranded DNA in a sample. Agarose 
gel electrophoresis should also be a standard requirement in QC 
to check DNA integrity. Running single nucleotide polymorphism 
(SNP) identification panels for each sample is recommended, but 
costly; therefore, in lower-resource settings a multiplex polymerase 
chain reaction assay for a small set of SNPs may be advised as a 
compromise. QC results are recorded in the laboratory information 
management system (LIMS), and monthly reports and other 
supporting documentation are stored electronically, in accordance 
with the quality management standards regarding document control 
outlined in the international standard for document storage (ISO 
9001:2015).[16] According to ISO 15489-1:2001, records should be 
created, stored, maintained and protected such that their accuracy, 
legibility and availability are ensured.[17] Along with secure access 
and user verification, audit trails through electronic logs should be 
available to comply with best practice guidelines, ethics regulations 
and international standards.[17] 
Laboratory information management 
system (LIMS)
Sample tracking and storage location management are key aspects of 
biobanking. The efficient management and tracking of samples as they 
are received, processed, aliquotted and shipped are best performed by 
the implementation of LIMS software. Data security is integral to the 
reliable and efficient management of samples and data in a biobank. 
The software should be secure, and access to data should only be 
granted to authorised users according to user-defined roles.
There are many commercial applications that offer comprehensive 
and fully auditable information and sample management, e.g. 
STARLIMS, Nautilus (ThermoScientific), CloudLIMS, LDMS and 
Gemini Matrix, to name a few. There are also software applications 
that only manage sample tracking, such as TD-Biobank and 
Freezerworks. Although these applications are fully integrated and 
supported, the costs may be prohibitive in a low-resource setting, as 
they may include annual licence fees, initial setup and customisation 
costs, and training by international companies. Choosing a LIMS 
depends on specific requirements, affordability and personnel. Open-
source software (OSS) may be preferable if resources are not 
available to dedicate to a LIMS. Software such as Bika LIMS and 
the Ark Informatics can be customised to suit the needs of any 
biobank, provided that a dedicated developer can be employed for 
customisation, support and implementation. The cost-effectiveness 
of using an OSS package is balanced against the cost of the developer, 
the regular updating of the software by its creators, the customisability 
of the software to one’s requirements, and the ease of implementation. 
The Ark Informatics is a secure open-source LIMS software 
application developed within the Centre for Genetic Epidemiology 
and Biostatistics at the University of Western Australia in 2009.[18] It is 
module-based software that allows one to store minimum participant 
data, including data specific to consent and a full sample-location 
management system. It has the capacity to produce records upon 
request, allowing for a full audit trail. Samples received may be 
logged manually or according to bulk upload features. Depending 
on the project, the Ark Informatics can incorporate data from a 
database or from spreadsheets to organise all data specific to sample 
storage (Fig. 2). The SBIMB’s version of the Ark was modified to suit 
our requirements, and allows automatic uploads from REDCap[19] 
or any other database in a seamless workflow. Despite initial 
Databases REDCap
Shipping manifests
Reports
• Study summary
• Study-level consent
• Biospecimen summary
• Biospecimen details
• Nucleic acid summary
Output data
The Ark informatics
• Study information
• Minimum participant data
• Biospecimen data
• Storage data
Spreadsheets
Input data
2013
Renovations complete
2014
Risk assessment
2015
Additional personnel training
2016
UCT biobanking conference
ESBB conference 
2015
2012    2013      2014                    2015                       2016            2017
2014 - 2015
Ark 
development
2015
Wits HREC ethics approval
Expansion
2014
Wits HREC/BEC Application
2012
Capital outlay for infrastructure
Fig. 2. Data management: Diagram depicting the various types of input data 
that may be imported into the Ark informatics LIMS, the type of data stored 
in its modules and examples of output data in the format of reports.
489       June 2017, Vol. 107, No. 6
IN PRACTICE
implementation challenges, it is easy to use 
and has the relevant features that commercial 
systems offer. 
The eB3Kit Biobank in a Box (Bibbox) 
(Austria), available through B3Africa, 
provides an integrated biobanking and 
bioinformatics platform.[8,20] This system 
consists of seven integrated work packages 
that monitor all aspects of biobanking, from 
the ethical and regulatory requirements, 
hardware and software requirements, a LIMS 
and bioinformatics platform, relevant training 
and dissemination and searchable datasets 
linked with biospecimens.[20] Once the eBiokit 
is purchased, the software is free and tools 
are available in the Bibbox ecosystem for 
personal customisation.[8,20] Currently Bika 
is being implemented, but support will also 
be available for Open Specimen.[8,20] Other 
LIMS can be hooked up to the eBiokit for 
bioinformatics analysis (Galaxy/Pulsar), 
experiment management, Open Data Kit 
(ODK) for data collection with mobile phones 
and ethics compliance support.[8,20] Had it 
been available when we started the SBIMB 
biobank, it would have been evaluated and 
considered before making a decision on the 
most suitable LIMS option.
Discussion 
The SBIMB biobank houses a valuable and 
constantly growing resource for multi-
disci plinary research in SA, and aims to 
be sustainable in the long term. Our main 
objective is to provide a high-quality 
bioresource, as well as expertise to support 
analysis of data and samples from African 
populations, so that we can better characterise, 
understand and apply our research findings 
to improve the health of Africans. The 
establishment of a national biobank in SA has 
been under discussion since 2013.[1,2] Lack of 
adequate financial resources and insufficient 
current local investment in national research 
infrastructure, as well as misconceptions 
regarding ownership of biospecimens, have 
to date confounded the development of a 
feasible model for a national biobank in 
SA. Developing sustainability models for 
biobanks in low-resource settings is essential, 
as the funds required to run a biobank on 
an annual basis are significant (Table 1). 
In accordance with best-practice guidelines, 
contingency plans should be considered in 
Table 1. Cost considerations for setting up a biobank in a low-resource setting
Category Item
A. Infrastructure
1. Building and power supply Physical building with demarcated areas specific to purpose
Air conditioning
Ventilation system (positive/negative pressure per requirements)
Redundant power supply, circuitry and installation (UPS, generators)
Surge/lightning protection
Access control systems
2. Equipment Security cameras and alarms
Storage equipment (freezers, fridges, liquid nitrogen tanks, cupboards)
Computer equipment (hardware and software)
Equipment for sample processing
Gel Doc (QC) and Thermal cycler (QC and PCR)
Sample quantitation equipment (NanoDrop/Qubit)
Gas monitors (if required)
Autoclave
Water purification system
Temperature monitors
Barcode printers and scanners
3. LIMS Commercial or open-source (with their associated costs)
B. Personnel
1. Staff Manager
Scientists
Data and IT manager
2. Training Good clinical and laboratory practice
International Air Transport Association* (IATA) certification
Occupational health, safety and environment
First aid
External quality assurance and accreditation
C. Maintenance
1. Calibration or accreditation Equipment
2. Temperature monitoring SMS service
Recalibration and servicing
3. Building Associated infrastructural costs
4. Equipment Annual services and recalibration
Continued ....
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the event of possible closure precipitated by 
a lack of sustained funding.[2,3] To mitigate 
such risk, support from large institutions 
(e.g. universities or the government), and the 
introduction of a ‘pay-for-services’ culture 
between collaborators and biobank users, 
would support sustainability. The SBIMB 
biobank has implemented a business model 
where researchers using the services pay 
according to their required needs, including 
the costs for the reagents and consumables 
used for their projects, personnel time and 
an annual storage fee.
Academic researchers from various 
uni versities in SA have initiated research 
into the feasibility of institution-based 
biobanks operating with a standard set 
of guidelines and an agreed-upon set of 
standard operating procedures regarding 
sample and data sharing, sample handling 
and QC. Perhaps the most feasible outcome 
for SA is the implementation of a virtual 
national network of collaborating biobanks, 
working according to harmonised standards 
and procedures. Developing a website listing 
the biobanks in SA, and cataloguing their 
respective studies and samples, will promote 
further collaboration, and will identify 
synergies to bolster national research efforts. 
Establishing the SBIMB biobank has 
provided insight into important consider-
ations that should be addressed in the 
planning stages of setting up an academic 
biobank. These include: necessity and 
feasibility (do you need to start your own 
biobank or can you use existing facilities?); 
ethical, legal and social considerations of 
setting up a biobank (governance, legislation 
and regulation); location; infrastructure 
(fit for purpose with suitable back-up 
strategies); storage (what sample types 
are being stored and at what temperature?); 
LIMS (commercial v. open source packages); 
accreditation or approval; and sustainability 
(have you developed a sustainable funding 
model?). Each of these considerations has been 
addressed in this article not only in terms of 
biobanking in general, but in an SA context, 
specifically in an academic setting. In Table 2 
we provide ten broad areas for consideration 
when planning to set up a biobank. We suggest 
key questions that should be addressed, and 
outline minimum requirements for a successful 
biobanking endeavour.
Setting up a biobank requires commitment, 
funding, institutional support, a team of 
dedicated researchers and considerable time. 
It took 3 years for the SBIMB biobank to be 
ready to process, store and provide high-
quality DNA samples for academic research, 
and to obtain approval from the Wits HREC 
(Medical) (Fig. 3). We have plans to expand 
the SBIMB biobank in order to increase 
our research and storage capacity, and to 
promote further cross-institutional and 
cross-disciplinary biomedical research. 
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Fig. 3. SBIMB Biobank timeline: Depicting the timeline for achieving milestones required for the biobank 
to become a high-quality, sustainable bioresource. These include the time taken for ethics approval and 
customisation and development of the Ark Informatics.
Table 1. (continued) Cost considerations for setting up a biobank in a low-resource setting
Category Item
D. Consumables
1. Storage Plates/tubes/vials
Boxes/racks
2. QC Electrophoresis consumables
Quantitation consumables or assays
3. General Other consumables including basic stationery
4. Processing Reagents and consumables
E. Overheads Telephone and internet access
Cleaning services
Security
Fire extinguishers
Emergency signage
Building maintenance
Biohazard waste removal
F. Shipping Costs related to shipping samples: frozen on dry ice, refrigerated,  
or at ambient shipping
*For regulations regarding transport of dangerous goods.
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Table 2. Ten important broad issues to consider when planning a biobank from scratch in a low-resource environment
Point Considerations and key questions Desired outcomes
1
Need and  
feasibility
Do you need to build your own biobank or can you use an 
existing institutional or external biobank?
Once you have established the need to develop a biobank, 
perform a detailed cost analysis and ensure that you have 
the necessary support from your institution.How long do you plan to store samples? May samples be used 
for future research?
Is there a favourable cost-benefit analysis?
Does your biobank need to be close to your research site?
Do you have the capital to fund a biobank? 
2
Ethical, legal  
and social 
considerations
What is required by your ethics committee for approval of your 
biobank for the storage of samples?
Ensure that you have a feasible governance process, 
certification or approval if required, and guidelines for 
researchers who plan to store their samples.
Legal and institutional compliance in terms of MTAs and 
import/export permits. 
Constitute a governing body consisting of independent 
oversight, regulation through ethics committees and 
internal governance structures. Members should be 
selected in order to represent all stakeholders, and to be 
representative of different expertise required.
What consent models would you require for the research 
sample collections to be used for future studies?
What is an appropriate governance framework?
How are members selected?
Could your policies and processes cause harm (to individuals, 
communities)?
Do you have templates for MTAs?
Do you have policies for sample and data withdrawal and 
disposal?
Is there a clear procedure in case of biobank closure? 
3
Location
Is it appropriate in terms of proximity to study sites? Once you have found a location that suits all of your 
requirements ensure that it is well-serviced and easy to 
get to.
Is there enough space?
Do you have access to water, power, and good transport routes?
How does location affect cost?
4
Infrastructure
Is your building fit-for-purpose? A secure, access-controlled biobank that is security-
monitored.
Backup systems in place for utility failures.
Budget set aside for maintenance of the building and 
equipment.
Is it secure and access-controlled?
Is the building large enough to house major equipment  
(and in terms of storage capacity)?
Has a risk assessment been performed?
Are there measures to ensure that there will always be water 
and electricity?
What are the maintenance costs for both the building and 
equipment?
5
Storage
What are the biospecimen types and volumes? Increased capacity by using vials appropriate to volume of 
samples.
Ambient, refrigerated, frozen short-term, or frozen long-
term at temperatures fit for sample type.
24/7 temperature monitoring systems with alarms and 
SMS or phone call notifications.
Barcodes (human readable, linear, 2D matrix)
How long will samples be stored? Is the storage temperature 
appropriate?
Is the temperature of storage equipment and ambient 
temperature in the laboratory being monitored?
How are your biospecimens identified?
6
LIMS
How are you keeping track of your samples? A secure functional LIMS which allows for appropriate 
and efficient sample tracking and management.Can your budget accommodate a commercial LIMS? Is open-
source development of an available package more affordable?
7
Staff
Do you have the available funds to support dedicated staff? Qualified, trained biobank personnel that are on medium- 
to long-term contracts or are permanent staff.Is there training in good laboratory practice?
Will your staff require any other training or certification?
8
Accreditation  
and quality
Is there national accreditation for biobanks in your country? An accredited biobank offering high-quality services.
Can you afford to do external quality control?
Can you afford international accreditation and certification?
Continued ....
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Table 2. (continued) Ten important broad issues to consider when planning a biobank from scratch in a low-resource environment
Point Considerations and key questions Desired outcomes
9
Sustainability
Do you have funds to sustain your biobank in the long term? A sustainability model for the biobank should be 
developed and implemented.
Funds from services rendered could contribute to 
sustainability.
Have you developed a business model for sustainability?
10
Time
How long will it take to establish a biobank? It can take years to set up a biobank; therefore, 
considerations of time investment should be taken into 
account.
Are investors or funders aware of the time involved?
